- Vented Vial Adapter
- Swabable Vial Adapter
Vial Adaptors for Reconstitution Drug market was valued at USD 1.18 billion and expected to grow at significant Compound Annual Growth Rate (CAGR) of 7% from 2023-2029. Vial adapters are the cost effective solution for safe and rapid transfer and reconstruction of drugs between vials and syringes. Vial adapter spike technology provides a reproducible engineered depth for the drug and diluent aspiration that generally decreases the variability of end user associated with the conventional needle aspirations and helps to reduce vial overfill. Market players are focus on product innovations and product launches to increase their market share and to sustain their positions in the Vial Adaptors for Reconstitution Drug market. Furthermore, companies adopting strategies such as mergers and acquisitions to strengthen their market. In 2011, West Pharmaceutical Services, Inc. provider of innovative system and component solutions for injectable drug administration, and CareFusion, a medical technology company, today entered into an agreement to develop and market jointly a new, needle-free vial access device. This initiative is part of a five year global distribution and supply agreement between the two companies
Vial Adaptors For Reconstitution Drug Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
7%
Largest Market
North America
Fastest Growing Market
Europe
Vial Adaptors for Reconstitution Drug Market Dynamics
Global Vial Adaptors for Reconstitution Drug market mainly has been seeing a spike sought after for items as they are more secure choices for exchanging diluents for reconstitution forms when contrasted with customary ways. These additionally limit the danger of potential needle stick damage. The market additionally stands to profit because of the developing pool of geriatrics, who are vulnerable to an extensive variety of ailments and scatters that require organization of medications through vial connectors. Besides, the high predominance of irresistible ailments is additionally prone to enlarge the interest for reconstitution drugs, which thusly will consider decidedly the interest for vial connectors required for the same. The developing interest for lyophilized medications has likewise increased the interest for vial connectors for reconstitution tranquilizes lately. The limitation in the global vial connectors for reconstitution drug market is the requirement for customization for particular items. This requests wide screening of off-the-rack organization of vial connectors, which is the greatest calculated issue for the worldwide market. Global Vial Adaptors for Reconstitution Drug market being hampered by accessibility of substitutes, for example, prefilled syringes and auto-injectors.
North-America Got Significant Share
Vial Adaptors for Reconstitution Drug Market Regional Analysis
Geographically, global Vial Adaptors for Reconstitution Drug market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America stayed prevailing in the worldwide Vial Adaptors for Reconstitution Drug market. Europe took after this lead intently. The high frequency of immune system ailments, rising mechanical progressions, and developing interest for without needle items prone to help the development of the vial connectors for Vial Adaptors for Reconstitution Drug market in North America. Vial Adaptors for Reconstitution Drug market in Europe will be energized by expanding progressions in human services innovation in the midst of rising security concerns. Asia Pacific is likewise liable to be a lucrative market for the vial connectors for reconstitution drugs amid the conjecture time frame. The developing selection of innovation, high commonness of immune system infections, for example, diabetes, and expanding reception of innovation are altogether anticipated that would make a critical commitment to the taking off vial connectors for reconstitution medicate showcase in Asia Pacific. This local market will likewise be moved by the swelling pool of geriatrics, who are inclined to different medicinal conditions and a tremendous pool of neglected therapeutic needs. The reinforcing economies of Asia Pacific and enhancing access to social insurance in the area are likewise prone to expand the interest for vial connectors for reconstitution drugs.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The vial adaptors for reconstitution drug market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startups details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis in addition to recent technology advancements and innovations in the market
Vial Adaptors For Reconstitution Drug Market Segmentation
By Type
By Application
- Autoimmune Diseases
- Infectious Diseases
- Metabolic Conditions
- Reproductive Health
- Others
By End User
- Hospitals
- Diagnostic Centres
- Ambulatory surgical centres
- Radiotherapy Centres
By Geography
- North America
- Europe
- Latin America
- Asia Pacific
- The Middle East and Africa.
Frequently Asked Questions
The Vial adaptors for reconstitution drug market size was valued at USD 1.18 billion in 2022.
The Vial adaptors for reconstitution drug market have been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The Vial adaptors for reconstitution drug market key players are Becton, Dickinson & Company (U.S.), Medtronic (U.S.), Revolutions Medical Corporation (U.S.), Retractable Technologies, Inc. (U.S.), Royal Imtech N.V. (Smiths Medical) (Netherlands), Terumo Corporation (Japan), Unilife Corporation (U.S.), Sol-Millennium Medical Group (China), Ultimed, Inc. (U.S.), Axel Bio Corporation (U.S.)
| 1.Executive Summary |
| 2.Global Vial Adaptors for Reconstitution Drug Market Introduction |
| 2.1.Global Vial Adaptors for Reconstitution Drug Market - Taxonomy |
| 2.2.Global Vial Adaptors for Reconstitution Drug Market - Definitions |
| 2.2.1.Type |
| 2.2.2.Application |
| 2.2.3.End User |
| 2.2.4.Region |
| 3.Global Vial Adaptors for Reconstitution Drug Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Vial Adaptors for Reconstitution Drug Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Vial Adaptors for Reconstitution Drug Market By Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Vented Vial Adapter |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Swabable Vial Adapter |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Vial Adaptors for Reconstitution Drug Market By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Autoimmune Diseases |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Infectious Diseases |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Metabolic Conditions |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Reproductive Health |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7.Global Vial Adaptors for Reconstitution Drug Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Diagnostic Centres |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Ambulatory surgical centres |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Radiotherapy Centres |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8.Global Vial Adaptors for Reconstitution Drug Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Vial Adaptors for Reconstitution Drug Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Vented Vial Adapter |
| 9.1.2.Swabable Vial Adapter |
| 9.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Autoimmune Diseases |
| 9.2.2.Infectious Diseases |
| 9.2.3.Metabolic Conditions |
| 9.2.4.Reproductive Health |
| 9.2.5.Others |
| 9.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Diagnostic Centres |
| 9.3.3.Ambulatory surgical centres |
| 9.3.4.Radiotherapy Centres |
| 9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Vial Adaptors for Reconstitution Drug Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Vented Vial Adapter |
| 10.1.2.Swabable Vial Adapter |
| 10.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Autoimmune Diseases |
| 10.2.2.Infectious Diseases |
| 10.2.3.Metabolic Conditions |
| 10.2.4.Reproductive Health |
| 10.2.5.Others |
| 10.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Diagnostic Centres |
| 10.3.3.Ambulatory surgical centres |
| 10.3.4.Radiotherapy Centres |
| 10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 10.4.7. |
| 11.Asia Pacific (APAC) Vial Adaptors for Reconstitution Drug Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Vented Vial Adapter |
| 11.1.2.Swabable Vial Adapter |
| 11.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Autoimmune Diseases |
| 11.2.2.Infectious Diseases |
| 11.2.3.Metabolic Conditions |
| 11.2.4.Reproductive Health |
| 11.2.5.Others |
| 11.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Diagnostic Centres |
| 11.3.3.Ambulatory surgical centres |
| 11.3.4.Radiotherapy Centres |
| 11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Vial Adaptors for Reconstitution Drug Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Vented Vial Adapter |
| 12.1.2.Swabable Vial Adapter |
| 12.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Autoimmune Diseases |
| 12.2.2.Infectious Diseases |
| 12.2.3.Metabolic Conditions |
| 12.2.4.Reproductive Health |
| 12.2.5.Others |
| 12.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Diagnostic Centres |
| 12.3.3.Ambulatory surgical centres |
| 12.3.4.Radiotherapy Centres |
| 12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Vial Adaptors for Reconstitution Drug Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Vented Vial Adapter |
| 13.1.2.Swabable Vial Adapter |
| 13.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Autoimmune Diseases |
| 13.2.2.Infectious Diseases |
| 13.2.3.Metabolic Conditions |
| 13.2.4.Reproductive Health |
| 13.2.5.Others |
| 13.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Diagnostic Centres |
| 13.3.3.Ambulatory surgical centres |
| 13.3.4.Radiotherapy Centres |
| 13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Becton, Dickinson & Company (U.S.) |
| 14.2.2.Medtronic (U.S.) |
| 14.2.3.Revolutions Medical Corporation (U.S.) |
| 14.2.4.Retractable Technologies, Inc. (U.S.) |
| 14.2.5.Royal Imtech N.V. (Smiths Medical) (Netherlands) |
| 14.2.6.Terumo Corporation (Japan) |
| 14.2.7.Unilife Corporation (U.S.) |
| 14.2.8.Sol-Millennium Medical Group (China) |
| 14.2.9.Ultimed, Inc. (U.S.) |
| 14.2.10.Axel Bio Corporation (U.S.) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- Becton, Dickinson & Company (U.S.)
- Medtronic (U.S.)
- Revolutions Medical Corporation (U.S.)
- Retractable Technologies, Inc. (U.S.)
- Royal Imtech N.V. (Smiths Medical) (Netherlands
- Terumo Corporation (Japan)
- Unilife Corporation (U.S.)
- Sol-Millennium Medical Group (China)
- Ultimed, Inc. (U.S.)
- Axel Bio Corporation (U.S.)